Developer docs
API playgroundTry for free, no card

Search company profiles

ExploraMed

Full company profile

uuid0002fna

Namestring
ExploraMed
Legal namestring
Exploramed Development LLC
Websiteurl
exploramed.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

ExploraMed is a venture-backed medical device incubator founded in 1995 and headquartered in Mountain View, California. The company identifies persistent unmet clinical needs across multiple therapeutic areas, including ENT, urology, orthopedics, women's health, obesity, and vascular access, and develops minimally invasive medical device solutions through dedicated portfolio companies. ExploraMed's business model is to create, fund, and operate medical device ventures through successive fund cycles (ExploraMed I through V), partnering primarily with New Enterprise Associates as its anchor investor, and ultimately spinning off or selling these companies to strategic acquirers.

ExploraMed has created 8 companies through four prior funds, generating notable exits including EndoMatrix (acquired by C.R. Bard in 1997), TransVascular (acquired by Medtronic in 2003), Acclarent (acquired by Johnson & Johnson in 2010), NeoTract (acquired by Teleflex for approximately $1.1 billion in 2017), Nuelle (acquired by Aytu Women's Health in 2017), and Revelle Aesthetics (acquired by Tiger Aesthetics in 2024). Current active portfolio companies include the X9 Ecosystem Platform (an AI-powered ultrasound-guided procedural guidance system), Moximed (Atlas System for knee osteoarthritis), Willow (mobile breast pump), and Vibrynt (Prevail obesity balloon implant).

The incubator operates a lean team of 11-50 employees led by Founder and Executive Chairman Joshua Makower, a Stanford University Professor of Medicine and BioEngineering who holds over 300 patents, alongside President and General Counsel Earl Bright. ExploraMed does not sell products directly to end consumers; instead, revenue mechanics derive from fund management fees, equity ownership in portfolio companies, and carried interest crystallized upon exits. Strategic partnerships with companies like DaVita (for X9) provide clinical validation channels and capital infusion for individual portfolio ventures.

Short descriptiontext

ExploraMed is a venture-backed medical device incubator founded in 1995 that identifies unmet clinical needs and develops minimally invasive device solutions through portfolio companies, partnering with New Enterprise Associates across multiple fund cycles.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device incubation, medtech venture creation, medical device innovation, unmet health needs, patient-driven devices
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Device Incubation
Social media profiles1 record
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ExploraMed is a medical device incubator that identifies persistent unmet health needs from the perspective of patients and physicians, then creates and funds standalone companies to develop cutting-edge, cost-effective device solutions. The incubator operates across multiple funds (I through V), partnering with New Enterprise Associates, and has spun out 8 companies to date, with current active portfolio companies including X9 (AI-ultrasound procedural ecosystem), Moximed (knee osteoarthritis implant), Willow (mobile breast pump), and Vibrynt (obesity balloon implant).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Successfully created 8 companies through four prior funds
+1 more record
Product overview1 text field

ExploraMed is a medical device incubator that develops and spin-offs multiple medical device companies. The current active portfolio includes the X9 Ecosystem Platform (a comprehensive hardware/software/services ecosystem with AI-powered ultrasound imaging), Moximed Atlas System (knee osteoarthritis implant), and Willow (mobile breast pump). Previously acquired companies include Acclarent (ENT devices, acquired by J&J), NeoTract/UroLift (urology devices, acquired by Teleflex), TransVascular (vascular access catheters, acquired by Medtronic), Nuelle (women's health devices, acquired by Aytu), Endomatrix (tissue bulking, acquired by CR Bard), and Revelle Aesthetics (aesthetic devices, acquired by Tiger Aesthetics). The incubator operates through multiple funding rounds (ExploraMed I through V) and partners with investors including New Enterprise Associates (NEA).

Product and service4 records
1X9 Ecosystem Platform
CategoryAI-Enabled Procedural Guidance Platform
Description

Comprehensive healthcare ecosystem combining hardware, software, and services with real-time AI-powered ultrasound imaging and micro-level precision for point-of-care procedures including vascular access, biopsies, nerve blocks, and tumor ablations.

2Willow Mobile Breast Pump
CategoryWomen's Health Consumer Medical Device
Description

All-in-one mobile breast pump that is cord-free, hands-free, and fits inside a bra, designed to allow breastfeeding mothers to pump discreetly without being tethered to a wall.

3Moximed Atlas System
CategoryOrthopedic Implant Device
Description

Minimally invasive joint-sparing implant system for early osteoarthritis of the knee, designed to reduce pain and improve function by unloading the knee joint.

4Vibrynt Prevail
CategoryBariatric Medical Device
Description

Minimally invasive saline-filled expandable balloon implant placed above the stomach in the abdominal cavity for treatment of obesity.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

DaVita invested in X9 through its venture group. X9 is developing an ultrasound-guided device for dialysis cannulation. DaVita is a leading dialysis provider seeking to reduce cannulation-related complications and costs while improving patient outcomes.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Silicon Valley medical device incubator founded by Mir Imran, with the same model of identifying unmet clinical needs and forming companies around novel medical devices. Comparable in scale, geography, and approach as a privately-held medtech venture studio.

TypeDirect peer
Description

Medical device incubator founded by Hanson Gifford that pioneered the venture studio model of creating multiple medtech companies from a single platform. Closely comparable to ExploraMed in approach, though it was acquired into Lightstone Ventures in 2017.

TypeDirect peer
Description

Medical device incubator founded by serial medical device inventors Howard Levin and Mark Gelfand. Uses a similar approach of identifying unmet clinical needs and forming companies to develop novel therapeutic devices.

TypeBroad incumbent
Description

Medical device incumbent that acquired ExploraMed's NeoTract for $1.1B in 2017. Comparable as a serial acquirer of venture-backed medtech companies and a relevant exit partner for future ExploraMed portfolio exits.

TypeBroad incumbent
Description

World's largest medical device company and ExploraMed's acquirer of TransVascular in 2003. Relevant as both a historical exit partner and a benchmark for the type of strategic acquirer ExploraMed targets.

TypeBroad incumbent
Description

Medical device incumbent that acquired ExploraMed's Acclarent in 2010. Board member Susan Morano previously led business development and strategic operations for J&J's $30B medtech group, evidencing the relationship.

TypeBroad incumbent
Description

Major medtech incumbent across cardiology, urology, and other specialties where ExploraMed has created portfolio companies. Board member Susan Morano serves on Boston Scientific's board, evidencing the relationship.

TypeBroad incumbent
Description

Major orthopedic medical device incumbent relevant given ExploraMed's Moximed portfolio (knee OA implant). Stryker is a likely strategic exit partner for orthopedic-focused ExploraMed companies.

TypeOthers
Description

Major venture capital firm and ExploraMed's long-term financial partner across all five fund cycles since 1996. As LP and co-investor in nearly every ExploraMed company, NEA is the most important financial ecosystem relationship for the incubator.

TypeOthers
Description

Stanford University program co-founded and directed by ExploraMed founder Joshua Makower. Serves as the primary talent and innovation pipeline for ExploraMed, with Biodesign Innovation Fellows frequently joining ExploraMed portfolio companies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment7 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ExploraMed

Medical Device Incubationexploramed.com

ExploraMed is a venture-backed medical device incubator founded in 1995 that identifies unmet clinical needs and develops minimally invasive device solutions through portfolio companies, partnering with New Enterprise Associates across multiple fund cycles.

What ExploraMed does

ExploraMed is a venture-backed medical device incubator founded in 1995 and headquartered in Mountain View, California. The company identifies persistent unmet clinical needs across multiple therapeutic areas, including ENT, urology, orthopedics, women's health, obesity, and vascular access, and develops minimally invasive medical device solutions through dedicated portfolio companies. ExploraMed's business model is to create, fund, and operate medical device ventures through successive fund cycles (ExploraMed I through V), partnering primarily with New Enterprise Associates as its anchor investor, and ultimately spinning off or selling these companies to strategic acquirers.

ExploraMed has created 8 companies through four prior funds, generating notable exits including EndoMatrix (acquired by C.R. Bard in 1997), TransVascular (acquired by Medtronic in 2003), Acclarent (acquired by Johnson & Johnson in 2010), NeoTract (acquired by Teleflex for approximately $1.1 billion in 2017), Nuelle (acquired by Aytu Women's Health in 2017), and Revelle Aesthetics (acquired by Tiger Aesthetics in 2024). Current active portfolio companies include the X9 Ecosystem Platform (an AI-powered ultrasound-guided procedural guidance system), Moximed (Atlas System for knee osteoarthritis), Willow (mobile breast pump), and Vibrynt (Prevail obesity balloon implant).

The incubator operates a lean team of 11-50 employees led by Founder and Executive Chairman Joshua Makower, a Stanford University Professor of Medicine and BioEngineering who holds over 300 patents, alongside President and General Counsel Earl Bright. ExploraMed does not sell products directly to end consumers; instead, revenue mechanics derive from fund management fees, equity ownership in portfolio companies, and carried interest crystallized upon exits. Strategic partnerships with companies like DaVita (for X9) provide clinical validation channels and capital infusion for individual portfolio ventures.

ExploraMed firmographics

Firmographics
Name
ExploraMed
Legal name
Exploramed Development LLC
Website
https://exploramed.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
ExploraMed is a venture-backed medical device incubator founded in 1995 that identifies unmet clinical needs and develops minimally invasive device solutions through portfolio companies, partnering with New Enterprise Associates across multiple fund cycles.
Ownership category
akta.pro rank

Where ExploraMed is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ExploraMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Others

Marketing channels1 record

ExploraMed product offering

Product offering

Core offering

ExploraMed is a medical device incubator that identifies persistent unmet health needs from the perspective of patients and physicians, then creates and funds standalone companies to develop cutting-edge, cost-effective device solutions. The incubator operates across multiple funds (I through V), partnering with New Enterprise Associates, and has spun out 8 companies to date, with current active portfolio companies including X9 (AI-ultrasound procedural ecosystem), Moximed (knee osteoarthritis implant), Willow (mobile breast pump), and Vibrynt (obesity balloon implant).

Product overview

ExploraMed is a medical device incubator that develops and spin-offs multiple medical device companies. The current active portfolio includes the X9 Ecosystem Platform (a comprehensive hardware/software/services ecosystem with AI-powered ultrasound imaging), Moximed Atlas System (knee osteoarthritis implant), and Willow (mobile breast pump). Previously acquired companies include Acclarent (ENT devices, acquired by J&J), NeoTract/UroLift (urology devices, acquired by Teleflex), TransVascular (vascular access catheters, acquired by Medtronic), Nuelle (women's health devices, acquired by Aytu), Endomatrix (tissue bulking, acquired by CR Bard), and Revelle Aesthetics (aesthetic devices, acquired by Tiger Aesthetics). The incubator operates through multiple funding rounds (ExploraMed I through V) and partners with investors including New Enterprise Associates (NEA).

Differentiator

Problem solved

Functional benefit

Products and services

  • X9 Ecosystem Platform Comprehensive healthcare ecosystem combining hardware, software, and services with real-time AI-powered ultrasound imaging and micro-level precision for point-of-care procedures including vascular access, biopsies, nerve blocks, and tumor ablations.
  • Willow Mobile Breast Pump All-in-one mobile breast pump that is cord-free, hands-free, and fits inside a bra, designed to allow breastfeeding mothers to pump discreetly without being tethered to a wall.
  • Moximed Atlas System Minimally invasive joint-sparing implant system for early osteoarthritis of the knee, designed to reduce pain and improve function by unloading the knee joint.
  • Vibrynt Prevail Minimally invasive saline-filled expandable balloon implant placed above the stomach in the abdominal cavity for treatment of obesity.

Quantifiable outcome

  • Successfully created 8 companies through four prior funds
  • +1 more outcomes

Companies that use ExploraMed

Customer profile

Segments1 record

Ideal customer profiles2 records

ExploraMed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

ExploraMed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DaVitaflagshipStrategic or Co-development PartnerDaVita invested in X9 through its venture group. X9 is developing an ultrasound-guided device for dialysis cannulation. DaVita is a leading dialysis provider seeking to reduce cannulation-related complications and costs while improving patient outcomes.

Scale indicators2 records

Recent moves7 records

Expansion highlights6 records

ExploraMed competitors and assessment

Company assessment

Direct peers

  • InCube Labs: Silicon Valley medical device incubator founded by Mir Imran, with the same model of identifying unmet clinical needs and forming companies around novel medical devices. Comparable in scale, geography, and approach as a privately-held medtech venture studio.
  • The Foundry: Medical device incubator founded by Hanson Gifford that pioneered the venture studio model of creating multiple medtech companies from a single platform. Closely comparable to ExploraMed in approach, though it was acquired into Lightstone Ventures in 2017.
  • Coridea: Medical device incubator founded by serial medical device inventors Howard Levin and Mark Gelfand. Uses a similar approach of identifying unmet clinical needs and forming companies to develop novel therapeutic devices.

Broad incumbents

  • Teleflex: Medical device incumbent that acquired ExploraMed's NeoTract for $1.1B in 2017. Comparable as a serial acquirer of venture-backed medtech companies and a relevant exit partner for future ExploraMed portfolio exits.
  • Medtronic: World's largest medical device company and ExploraMed's acquirer of TransVascular in 2003. Relevant as both a historical exit partner and a benchmark for the type of strategic acquirer ExploraMed targets.
  • Johnson & Johnson MedTech: Medical device incumbent that acquired ExploraMed's Acclarent in 2010. Board member Susan Morano previously led business development and strategic operations for J&J's $30B medtech group, evidencing the relationship.
  • Boston Scientific: Major medtech incumbent across cardiology, urology, and other specialties where ExploraMed has created portfolio companies. Board member Susan Morano serves on Boston Scientific's board, evidencing the relationship.
  • Stryker: Major orthopedic medical device incumbent relevant given ExploraMed's Moximed portfolio (knee OA implant). Stryker is a likely strategic exit partner for orthopedic-focused ExploraMed companies.

Others

  • New Enterprise Associates (NEA): Major venture capital firm and ExploraMed's long-term financial partner across all five fund cycles since 1996. As LP and co-investor in nearly every ExploraMed company, NEA is the most important financial ecosystem relationship for the incubator.
  • Stanford Byers Center for Biodesign: Stanford University program co-founded and directed by ExploraMed founder Joshua Makower. Serves as the primary talent and innovation pipeline for ExploraMed, with Biodesign Innovation Fellows frequently joining ExploraMed portfolio companies.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

ExploraMed social profiles

Digital presence

ExploraMed compliance and trust

Trust signal

Compliance1 record

ExploraMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ExploraMed leadership team

Management profile

Number of profiles

Profiles10 records

ExploraMed subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

ExploraMed funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ExploraMed M&A and investment

M&A and investment

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ExploraMed

What does ExploraMed do?

ExploraMed is a medical device incubator that identifies persistent unmet health needs from the perspective of patients and physicians, then creates and funds standalone companies to develop cutting-edge, cost-effective device solutions. The incubator operates across multiple funds (I through V), partnering with New Enterprise Associates, and has spun out 8 companies to date, with current active portfolio companies including X9 (AI-ultrasound procedural ecosystem), Moximed (knee osteoarthritis implant), Willow (mobile breast pump), and Vibrynt (obesity balloon implant).

Is ExploraMed a public or private company?

ExploraMed is a private company. It is classified as venture growth investor backed and is currently operating.

When was ExploraMed founded?

ExploraMed was founded in 1996. It employs 11 to 50 people.

Where is ExploraMed based?

ExploraMed is headquartered in Mountain View, United States, in the North America region.

Who are ExploraMed's main competitors?

Direct peers on record are InCube Labs, The Foundry and Coridea. Broad incumbents are Teleflex, Medtronic, Johnson & Johnson MedTech, Boston Scientific and Stryker. Others are New Enterprise Associates (NEA) and Stanford Byers Center for Biodesign.

Does ExploraMed have an API?

No public API is recorded for ExploraMed.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals